Objectives: To estimate the incidence of diabetes, acute myocardial infarction (AMI), and stroke; and to determine factors associated with diabetes, AMI, and stroke incidence among patients previously treated for tuberculosis (TB) disease.
Introduction
Increasing evidence suggest that tuberculosis (TB) disease may disrupt host metabolism and contribute to subsequent risks of chronic non-communicable diseases (NCDs) (Huaman et al., 2017 , Kamper-Jorgensen et al., 2015 , Sheu et al., 2010 . Importantly, the majority of TB patients reside in low-and middle-income countries where chronic NCDs such as type-2 diabetes (diabetes), acute myocardial infarction (AMI), and stroke are increasingly threatening public health achievements (Gaziano et al., 2010) .
Diabetes is a well-established risk factor for TB infection (Lee et al., 2017) , TB disease, and poor TB treatment outcomes (Riza et al., 2014) . However, epidemiologic data to support the relationship between TB and risk of NCDs are scarce. Chlamydia pneumoniae, Helicobacter pylori, influenza, and HIV are associated with cardiovascular disease risk, likely due to chronic systemic inflammation that can lead to atherosclerotic lesions (Huaman et al., 2015) . However, whether individual-level TB risk factors (e.g., comorbidities, treatment duration, site of infection) increase the risk of post-infection incident NCDs is unknown. Therefore, among a large cohort of patients post-TB treatment, we aimed to estimate the incidence rates of diabetes, AMI, and stroke and to determine characteristics associated with these incident NCDs.
Methods
We conducted a cohort study among patients formerly treated for TB disease using data from the Taiwan National Health Insurance Research Database(NHIRD)during2002-2013. NHIRD is maintained by the National Health Research Institute and contains original registration and insurance claim data from the single-payer national health insurance system which covers 99.9% of the Taiwanese population.
Eligible patients included those with non-pediatric active TB disease (≥15 years old for DM study; ≥25 years old for AMI and stroke studies) confirmed by ICD-9 codes (010-018) and prescriptions of anti-TB drugs for ≥28 days within a year. The earliest date of TB diagnosis indicated by ICD-9 codes was defined as the TB date. Patients with ICD-9 diagnoses of diabetes, AMI, or stroke on or before date of TB disease were excluded. Incident diabetes was defined as patients who received anti-diabetes drug prescriptions for ≥28 days within a year and a confirmed diabetes ICD-9 (250.X0 or 250.X2) first indicated ≥2 years after TB date. Incident AMI (ICD-9 410.XX) and stroke (ICD-9 430.XX -438.XX) were defined by ICD-9 codes and ≥3 out-patient clinic visits or 1 hospitalization indicated ≥1 year after TB date. Other comorbidity characteristics including dyslipidemia, hypertension, overweight, HIV, and chronic kidney diseases (CKD) were determined by ICD-9 codes. We calculated incidence of diabetes, AMI, and stroke using Poisson regression, and proportional hazards regression was used to estimate relative hazards of NCDs incidence. Incidence rates (IR) were presented per 1000 person-years. Patients were censored if they left the insurance system or did not develop diabetes, AMI, or stroke by the end of follow-up (December 2013).
Results
During the study period, there were 157,444 patients treated for TB disease and 1315 were <15 years and excluded. Among adult TB cases, 82.9% (129,453/156,129) patients did not have prior diabetes diagnosis; 98.0% (143,678/146,646) did not have prior history of AMI; and 81.0% (118,774/146,646) did not have prior stroke diagnosis (Supplemental Material 1) and were included. Among those without preexisting diabetes, 2479 incident diabetes diagnoses occurred during 643,754 person-years (age-adjusted IR 3.85, 95%CI 3.70-4.01) ( Table 1 ). The median time of incident diabetes post TB date was 7 years (IQR 5-9) (Supplemental Material 2). In the adjusted model, TB patients with pre-existing dyslipidemia (adjusted hazard ratio [aHR] 1.41; 95%CI 1.25-1.58), hypertension (aHR 1.78, 95%CI 1.62-1.94), and overweight (aHR 2.67, 95%CI 1.76-4.03) had increased risk of diabetes post-TB treatment ( Table 2 ).
The age-adjusted IR of AMI was 3.26 (95%CI 3.13-3.40), and 16.08 (95%CI 15.76-16.32) for stroke. The median time of incident AMI and stroke post-TB date was 6 years (IQR 3-8) and 6 years (IQR 3-9), respectively. In the adjusted models, factors predictive of incident AMI and stroke included pre-existing dyslipidemia (aHR AMI 1.29, 95%CI 1.17-1.43; aHR stroke 1.20, 95%CI 1.13-1.27), hypertension (aHR AMI 1.70, 95%CI 1.54-1.86; aHR stroke 1.67, 95% CI 1.60-1.75), CKD (aHR AMI 1.86,95%CI 1.65-2.11; aHR stroke 1.26, 95%CI 1.17-1.36), and diabetes (aHR AMI 1.96,95%CI 1.79-2.14; aHR stroke 1.47, 95%CI 1.40-1.54).
Discussion
Our preliminary findings suggest that older age, male gender, and traditional pre-existing chronic NCDs are predictive of diabetes, AMI, and stroke incidence post-TB treatment. Although overall TB treatment duration was not predictive of diabetes, AMI, and stroke incidence, we found that patients treated for 7-12 months had higher incidence of NCDs compared to those treated for ≤6 months. Furthermore, our incidence estimation of diabetes, AMI, and stroke were higher when compared to previous Taiwanese national estimates using NHIRD database. For example, the annual age-standardized incidence rate of diabetes was <1% across Taiwanese population (Jiang et al., 2012) . Additionally, the age and genderadjusted incidence of AMI was 50.7/100,000 persons in 2015 (Lee et al., 2018) and the estimated stroke incidence was 12.3/1000 person-years (Chan et al., 2018) . Our results highlight the need for studies to determine the impact of TB disease on risk of NCDs; such studies will require substantial follow-up time and a control group without TB disease.
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